About stereotaxis inc - STXS
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
STXS At a Glance
Stereotaxis, Inc.
710 North Tucker Boulevard
St. Louis, Missouri 63101
| Phone | 1-314-678-6100 | Revenue | 32.38M | |
| Industry | Medical Specialties | Net Income | -21,643,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 20.28% | |
| Fiscal Year-end | 12 / 2026 | Employees | 131 | |
| View SEC Filings |
STXS Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 6.461 |
| Price to Book Ratio | 16.265 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -11.247 |
| Enterprise Value to Sales | 6.377 |
| Total Debt to Enterprise Value | 0.026 |
STXS Efficiency
| Revenue/Employee | 247,152.672 |
| Income Per Employee | -165,213.74 |
| Receivables Turnover | 3.186 |
| Total Asset Turnover | 0.654 |
STXS Liquidity
| Current Ratio | 1.509 |
| Quick Ratio | 1.081 |
| Cash Ratio | 0.60 |
STXS Profitability
| Gross Margin | 52.726 |
| Operating Margin | -61.50 |
| Pretax Margin | -66.847 |
| Net Margin | -66.847 |
| Return on Assets | -43.734 |
| Return on Equity | -143.555 |
| Return on Total Capital | -89.593 |
| Return on Invested Capital | -107.189 |
STXS Capital Structure
| Total Debt to Total Equity | 29.037 |
| Total Debt to Total Capital | 22.503 |
| Total Debt to Total Assets | 10.404 |
| Long-Term Debt to Equity | 35.561 |
| Long-Term Debt to Total Capital | 19.845 |